Vaccine against deadly Bundibugyo Ebola strain could be ready by end of year
Share:
A vaccine targeting the dangerous Bundibugyo strain of Ebola could be available for deployment by the end of 2024, according to the Africa Centers for Disease Control and Prevention. The announcement represents a breakthrough in combating this particular Ebola variant, for which no approved vaccine or specific treatment currently exists. The development comes as the Democratic Republic of Congo faces an ongoing outbreak that has already claimed 246 lives. The Bundibugyo strain is one of several Ebola virus variants, and unlike the more common Zaire strain for which vaccines exist, this variant has lacked targeted medical countermeasures until now.